These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A comparison of the neuromuscular blocking effects of atracurium, mivacurium, and vecuronium on the adductor pollicis and the orbicularis oculi muscle in humans. Rimaniol JM; Dhonneur G; Sperry L; Duvaldestin P Anesth Analg; 1996 Oct; 83(4):808-13. PubMed ID: 8831326 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the neuromuscular blocking effect of atracurium and vecuronium on the adductor pollicis and the geniohyoid muscle in humans. D'Honneur G; Guignard B; Slavov V; Ruggier R; Duvaldestin P Anesthesiology; 1995 Mar; 82(3):649-54. PubMed ID: 7879933 [TBL] [Abstract][Full Text] [Related]
4. The clinical neuromuscular pharmacology of cisatracurium versus vecuronium during outpatient anesthesia. Stevens JB; Walker SC; Fontenot JP Anesth Analg; 1997 Dec; 85(6):1278-83. PubMed ID: 9390594 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of cumulative properties of three new nondepolarizing neuromuscular blocking drugs BW A444U, atracurium and vecuronium. Ali HH; Savarese JJ; Basta SJ; Sunder N; Gionfriddo M Br J Anaesth; 1983; 55 Suppl 1():107S-111S. PubMed ID: 6134539 [TBL] [Abstract][Full Text] [Related]
6. [Spontaneous development of paralysis induced by equipotent doses of vecuronium, atracurium, fazadinium, pancuronium, gallamine and d-tubocurarine]. Baurain M; Dernovoi B; Lefebvre R; Barvais L; d'Hollander A; Duvaldestin P; Hennart D Ann Fr Anesth Reanim; 1987; 6(6):493-7. PubMed ID: 2894787 [TBL] [Abstract][Full Text] [Related]
7. Comparison of duration of neuromuscular blocking effect of atracurium and vecuronium in young and elderly patients. Slavov V; Khalil M; Merle JC; Agostini MM; Ruggier R; Duvaldestin P Br J Anaesth; 1995 Jun; 74(6):709-11. PubMed ID: 7640130 [TBL] [Abstract][Full Text] [Related]
11. [Pharmacodynamics and clinical adverse effects of mivacurium. The effect of oral premedication with H1/H2 antagonists]. Mayer M; Doenicke A; Nebauer AE; Rosenberger C; Lorenz W; Peter K Anaesthesist; 1993 Sep; 42(9):592-6. PubMed ID: 8105716 [TBL] [Abstract][Full Text] [Related]
12. A comparison of the neuromuscular blocking effects and reversibility of cisatracurium and atracurium. Carroll MT; Mirakhur RK; Lowry D; Glover P; Kerr CJ Anaesthesia; 1998 Aug; 53(8):744-8. PubMed ID: 9797517 [TBL] [Abstract][Full Text] [Related]
13. Neuromuscular interaction between cisatracurium and mivacurium, atracurium, vecuronium or rocuronium administered in combination. Kim KS; Chun YS; Chon SU; Suh JK Anaesthesia; 1998 Sep; 53(9):872-8. PubMed ID: 9849281 [TBL] [Abstract][Full Text] [Related]
14. Recovery of neuromuscular function after atracurium and pancuronium maintenance of pancuronium block. Whalley DG; Lewis B; Bedocs NM Can J Anaesth; 1994 Jan; 41(1):31-5. PubMed ID: 8111941 [TBL] [Abstract][Full Text] [Related]
15. Effects of two benzodiazepines and a benzodiazepine antagonist on neuromuscular blockade in the anaesthetized cat. Driessen JJ; van Egmond J; van der Pol F; Crul JF Arch Int Pharmacodyn Ther; 1987 Mar; 286(1):58-70. PubMed ID: 2884940 [TBL] [Abstract][Full Text] [Related]
16. The effect of phenytoin on the magnitude and duration of neuromuscular block following atracurium or vecuronium. Ornstein E; Matteo RS; Schwartz AE; Silverberg PA; Young WL; Diaz J Anesthesiology; 1987 Aug; 67(2):191-6. PubMed ID: 2886081 [TBL] [Abstract][Full Text] [Related]
17. Is recovery of neuromuscular transmission complete after the use of neostigmine to antagonize block produced by rocuronium, vecuronium, atracurium and pancuronium? Baurain MJ; Hoton F; D'Hollander AA; Cantraine FR Br J Anaesth; 1996 Oct; 77(4):496-9. PubMed ID: 8942335 [TBL] [Abstract][Full Text] [Related]
19. Dose-response relationships for edrophonium and neostigmine as antagonists of atracurium and vecuronium neuromuscular blockade. Smith CE; Donati F; Bevan DR Anesthesiology; 1989 Jul; 71(1):37-43. PubMed ID: 2568767 [TBL] [Abstract][Full Text] [Related]
20. Effects of midazolam (Ro 21-3981) on neuromuscular block. Tassonyi E Pharmatherapeutica; 1984; 3(10):678-81. PubMed ID: 6463067 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]